ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Insulin Raw Material Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-0V10225
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Insulin Raw Material Market Research Report 2022
BUY CHAPTERS

Global Insulin Raw Material Market Research Report 2025

Code: QYRE-Auto-0V10225
Report
February 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novo Nordisk
Sanofi Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon Ltd.
Amphastar
WOCKHARDT
Julphar Diabetes
Torrent Pharma

Insulin Raw Material Market Size

The global market for Insulin Raw Material was valued at US$ 2073 million in the year 2024 and is projected to reach a revised size of US$ 2646 million by 2031, growing at a CAGR of 3.6% during the forecast period.

Insulin Raw Material Market

Insulin Raw Material Market

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China. In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.
The Insulin Raw Material market is driven by the increasing prevalence of diabetes and the growing demand for insulin production to address the global healthcare burden. Insulin, a vital hormone for managing blood sugar levels, requires high-quality raw materials for its synthesis. The rise in diabetes cases, both type 1 and type 2, contributes to market growth as pharmaceutical companies seek reliable sources of raw materials to meet the escalating insulin demand. Moreover, advancements in biotechnology and genetic engineering align with improved insulin production methods and potential innovations in insulin analogs. However, the market also faces challenges, including the complexity of insulin production processes and the need to adhere to stringent regulatory standards for quality and safety. Additionally, addressing affordability concerns and potential supply chain disruptions can pose obstacles for manufacturers. To succeed, companies must focus on sustainable sourcing, research and development for efficient production methods, and addressing the challenges to meet the increasing demand for insulin while ensuring its accessibility to a diverse diabetic population worldwide.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Insulin Raw Material, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Raw Material.
The Insulin Raw Material market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Insulin Raw Material market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Raw Material manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Insulin Raw Material Market Report

Report Metric Details
Report Name Insulin Raw Material Market
Accounted market size in year US$ 2073 million
Forecasted market size in 2031 US$ 2646 million
CAGR 3.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Regular Human Insulin
  • Insulin Analogue
Segment by Application
  • Fast-acting
  • Intermediate-acting
  • Long-acting
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novo Nordisk, Sanofi-Aventis, Eli Lilly, Tonghua Dongbao, Ganlee, United Laboratory, Biocon, Amphastar, Wockhardt, Julphar Diabetes, Torrent Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Insulin Raw Material manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Insulin Raw Material in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Insulin Raw Material Market growing?

Ans: The Insulin Raw Material Market witnessing a CAGR of 3.6% during the forecast period 2025-2031.

What is the Insulin Raw Material Market size in 2031?

Ans: The Insulin Raw Material Market size in 2031 will be US$ 2646 million.

Who are the main players in the Insulin Raw Material Market report?

Ans: The main players in the Insulin Raw Material Market are Novo Nordisk, Sanofi-Aventis, Eli Lilly, Tonghua Dongbao, Ganlee, United Laboratory, Biocon, Amphastar, Wockhardt, Julphar Diabetes, Torrent Pharma

What are the Application segmentation covered in the Insulin Raw Material Market report?

Ans: The Applications covered in the Insulin Raw Material Market report are Fast-acting, Intermediate-acting, Long-acting

What are the Type segmentation covered in the Insulin Raw Material Market report?

Ans: The Types covered in the Insulin Raw Material Market report are Regular Human Insulin, Insulin Analogue

1 Insulin Raw Material Market Overview
1.1 Product Definition
1.2 Insulin Raw Material by Type
1.2.1 Global Insulin Raw Material Market Value Comparison by Type (2024 VS 2031)
1.2.2 Regular Human Insulin
1.2.3 Insulin Analogue
1.3 Insulin Raw Material by Application
1.3.1 Global Insulin Raw Material Market Value by Application (2024 VS 2031)
1.3.2 Fast-acting
1.3.3 Intermediate-acting
1.3.4 Long-acting
1.4 Global Insulin Raw Material Market Size Estimates and Forecasts
1.4.1 Global Insulin Raw Material Revenue 2020-2031
1.4.2 Global Insulin Raw Material Sales 2020-2031
1.4.3 Global Insulin Raw Material Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Insulin Raw Material Market Competition by Manufacturers
2.1 Global Insulin Raw Material Sales Market Share by Manufacturers (2020-2025)
2.2 Global Insulin Raw Material Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Insulin Raw Material Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Insulin Raw Material, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insulin Raw Material, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Raw Material, Product Type & Application
2.7 Global Key Manufacturers of Insulin Raw Material, Date of Enter into This Industry
2.8 Global Insulin Raw Material Market Competitive Situation and Trends
2.8.1 Global Insulin Raw Material Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Insulin Raw Material Players Market Share by Revenue
2.8.3 Global Insulin Raw Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Insulin Raw Material Market Scenario by Region
3.1 Global Insulin Raw Material Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Insulin Raw Material Sales by Region: 2020-2031
3.2.1 Global Insulin Raw Material Sales by Region: 2020-2025
3.2.2 Global Insulin Raw Material Sales by Region: 2026-2031
3.3 Global Insulin Raw Material Revenue by Region: 2020-2031
3.3.1 Global Insulin Raw Material Revenue by Region: 2020-2025
3.3.2 Global Insulin Raw Material Revenue by Region: 2026-2031
3.4 North America Insulin Raw Material Market Facts & Figures by Country
3.4.1 North America Insulin Raw Material Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Insulin Raw Material Sales by Country (2020-2031)
3.4.3 North America Insulin Raw Material Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Insulin Raw Material Market Facts & Figures by Country
3.5.1 Europe Insulin Raw Material Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Insulin Raw Material Sales by Country (2020-2031)
3.5.3 Europe Insulin Raw Material Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Raw Material Market Facts & Figures by Region
3.6.1 Asia Pacific Insulin Raw Material Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Insulin Raw Material Sales by Region (2020-2031)
3.6.3 Asia Pacific Insulin Raw Material Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Insulin Raw Material Market Facts & Figures by Country
3.7.1 Latin America Insulin Raw Material Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Insulin Raw Material Sales by Country (2020-2031)
3.7.3 Latin America Insulin Raw Material Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Raw Material Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Raw Material Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Insulin Raw Material Sales by Country (2020-2031)
3.8.3 Middle East and Africa Insulin Raw Material Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Insulin Raw Material Sales by Type (2020-2031)
4.1.1 Global Insulin Raw Material Sales by Type (2020-2025)
4.1.2 Global Insulin Raw Material Sales by Type (2026-2031)
4.1.3 Global Insulin Raw Material Sales Market Share by Type (2020-2031)
4.2 Global Insulin Raw Material Revenue by Type (2020-2031)
4.2.1 Global Insulin Raw Material Revenue by Type (2020-2025)
4.2.2 Global Insulin Raw Material Revenue by Type (2026-2031)
4.2.3 Global Insulin Raw Material Revenue Market Share by Type (2020-2031)
4.3 Global Insulin Raw Material Price by Type (2020-2031)
5 Segment by Application
5.1 Global Insulin Raw Material Sales by Application (2020-2031)
5.1.1 Global Insulin Raw Material Sales by Application (2020-2025)
5.1.2 Global Insulin Raw Material Sales by Application (2026-2031)
5.1.3 Global Insulin Raw Material Sales Market Share by Application (2020-2031)
5.2 Global Insulin Raw Material Revenue by Application (2020-2031)
5.2.1 Global Insulin Raw Material Revenue by Application (2020-2025)
5.2.2 Global Insulin Raw Material Revenue by Application (2026-2031)
5.2.3 Global Insulin Raw Material Revenue Market Share by Application (2020-2031)
5.3 Global Insulin Raw Material Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Insulin Raw Material Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk Insulin Raw Material Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi-Aventis
6.2.1 Sanofi-Aventis Company Information
6.2.2 Sanofi-Aventis Description and Business Overview
6.2.3 Sanofi-Aventis Insulin Raw Material Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi-Aventis Insulin Raw Material Product Portfolio
6.2.5 Sanofi-Aventis Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Company Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Insulin Raw Material Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli Lilly Insulin Raw Material Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Tonghua Dongbao
6.4.1 Tonghua Dongbao Company Information
6.4.2 Tonghua Dongbao Description and Business Overview
6.4.3 Tonghua Dongbao Insulin Raw Material Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Tonghua Dongbao Insulin Raw Material Product Portfolio
6.4.5 Tonghua Dongbao Recent Developments/Updates
6.5 Ganlee
6.5.1 Ganlee Company Information
6.5.2 Ganlee Description and Business Overview
6.5.3 Ganlee Insulin Raw Material Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Ganlee Insulin Raw Material Product Portfolio
6.5.5 Ganlee Recent Developments/Updates
6.6 United Laboratory
6.6.1 United Laboratory Company Information
6.6.2 United Laboratory Description and Business Overview
6.6.3 United Laboratory Insulin Raw Material Sales, Revenue and Gross Margin (2020-2025)
6.6.4 United Laboratory Insulin Raw Material Product Portfolio
6.6.5 United Laboratory Recent Developments/Updates
6.7 Biocon
6.7.1 Biocon Company Information
6.7.2 Biocon Description and Business Overview
6.7.3 Biocon Insulin Raw Material Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Biocon Insulin Raw Material Product Portfolio
6.7.5 Biocon Recent Developments/Updates
6.8 Amphastar
6.8.1 Amphastar Company Information
6.8.2 Amphastar Description and Business Overview
6.8.3 Amphastar Insulin Raw Material Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Amphastar Insulin Raw Material Product Portfolio
6.8.5 Amphastar Recent Developments/Updates
6.9 Wockhardt
6.9.1 Wockhardt Company Information
6.9.2 Wockhardt Description and Business Overview
6.9.3 Wockhardt Insulin Raw Material Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Wockhardt Insulin Raw Material Product Portfolio
6.9.5 Wockhardt Recent Developments/Updates
6.10 Julphar Diabetes
6.10.1 Julphar Diabetes Company Information
6.10.2 Julphar Diabetes Description and Business Overview
6.10.3 Julphar Diabetes Insulin Raw Material Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Julphar Diabetes Insulin Raw Material Product Portfolio
6.10.5 Julphar Diabetes Recent Developments/Updates
6.11 Torrent Pharma
6.11.1 Torrent Pharma Company Information
6.11.2 Torrent Pharma Description and Business Overview
6.11.3 Torrent Pharma Insulin Raw Material Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Torrent Pharma Insulin Raw Material Product Portfolio
6.11.5 Torrent Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Raw Material Industry Chain Analysis
7.2 Insulin Raw Material Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Raw Material Production Mode & Process Analysis
7.4 Insulin Raw Material Sales and Marketing
7.4.1 Insulin Raw Material Sales Channels
7.4.2 Insulin Raw Material Distributors
7.5 Insulin Raw Material Customer Analysis
8 Insulin Raw Material Market Dynamics
8.1 Insulin Raw Material Industry Trends
8.2 Insulin Raw Material Market Drivers
8.3 Insulin Raw Material Market Challenges
8.4 Insulin Raw Material Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novo Nordisk
Sanofi Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon Ltd.
Amphastar
WOCKHARDT
Julphar Diabetes
Torrent Pharma
List of Tables
 Table 1. Global Insulin Raw Material Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Insulin Raw Material Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Insulin Raw Material Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Insulin Raw Material Sales (MT) of Key Manufacturers (2020-2025)
 Table 5. Global Insulin Raw Material Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Insulin Raw Material Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Insulin Raw Material Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Insulin Raw Material Average Price (US$/Kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Insulin Raw Material, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Insulin Raw Material, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Insulin Raw Material, Product Type & Application
 Table 12. Global Key Manufacturers of Insulin Raw Material, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Insulin Raw Material by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Raw Material as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Insulin Raw Material Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Insulin Raw Material Sales by Region (2020-2025) & (MT)
 Table 18. Global Insulin Raw Material Sales Market Share by Region (2020-2025)
 Table 19. Global Insulin Raw Material Sales by Region (2026-2031) & (MT)
 Table 20. Global Insulin Raw Material Sales Market Share by Region (2026-2031)
 Table 21. Global Insulin Raw Material Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Insulin Raw Material Revenue Market Share by Region (2020-2025)
 Table 23. Global Insulin Raw Material Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Insulin Raw Material Revenue Market Share by Region (2026-2031)
 Table 25. North America Insulin Raw Material Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Insulin Raw Material Sales by Country (2020-2025) & (MT)
 Table 27. North America Insulin Raw Material Sales by Country (2026-2031) & (MT)
 Table 28. North America Insulin Raw Material Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Insulin Raw Material Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Insulin Raw Material Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Insulin Raw Material Sales by Country (2020-2025) & (MT)
 Table 32. Europe Insulin Raw Material Sales by Country (2026-2031) & (MT)
 Table 33. Europe Insulin Raw Material Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Insulin Raw Material Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Insulin Raw Material Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Insulin Raw Material Sales by Region (2020-2025) & (MT)
 Table 37. Asia Pacific Insulin Raw Material Sales by Region (2026-2031) & (MT)
 Table 38. Asia Pacific Insulin Raw Material Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Insulin Raw Material Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Insulin Raw Material Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Insulin Raw Material Sales by Country (2020-2025) & (MT)
 Table 42. Latin America Insulin Raw Material Sales by Country (2026-2031) & (MT)
 Table 43. Latin America Insulin Raw Material Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Insulin Raw Material Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Insulin Raw Material Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Insulin Raw Material Sales by Country (2020-2025) & (MT)
 Table 47. Middle East and Africa Insulin Raw Material Sales by Country (2026-2031) & (MT)
 Table 48. Middle East and Africa Insulin Raw Material Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Insulin Raw Material Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Insulin Raw Material Sales (MT) by Type (2020-2025)
 Table 51. Global Insulin Raw Material Sales (MT) by Type (2026-2031)
 Table 52. Global Insulin Raw Material Sales Market Share by Type (2020-2025)
 Table 53. Global Insulin Raw Material Sales Market Share by Type (2026-2031)
 Table 54. Global Insulin Raw Material Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Insulin Raw Material Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Insulin Raw Material Revenue Market Share by Type (2020-2025)
 Table 57. Global Insulin Raw Material Revenue Market Share by Type (2026-2031)
 Table 58. Global Insulin Raw Material Price (US$/Kg) by Type (2020-2025)
 Table 59. Global Insulin Raw Material Price (US$/Kg) by Type (2026-2031)
 Table 60. Global Insulin Raw Material Sales (MT) by Application (2020-2025)
 Table 61. Global Insulin Raw Material Sales (MT) by Application (2026-2031)
 Table 62. Global Insulin Raw Material Sales Market Share by Application (2020-2025)
 Table 63. Global Insulin Raw Material Sales Market Share by Application (2026-2031)
 Table 64. Global Insulin Raw Material Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Insulin Raw Material Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Insulin Raw Material Revenue Market Share by Application (2020-2025)
 Table 67. Global Insulin Raw Material Revenue Market Share by Application (2026-2031)
 Table 68. Global Insulin Raw Material Price (US$/Kg) by Application (2020-2025)
 Table 69. Global Insulin Raw Material Price (US$/Kg) by Application (2026-2031)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 73. Novo Nordisk Insulin Raw Material Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. Sanofi-Aventis Company Information
 Table 76. Sanofi-Aventis Description and Business Overview
 Table 77. Sanofi-Aventis Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 78. Sanofi-Aventis Insulin Raw Material Product
 Table 79. Sanofi-Aventis Recent Developments/Updates
 Table 80. Eli Lilly Company Information
 Table 81. Eli Lilly Description and Business Overview
 Table 82. Eli Lilly Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 83. Eli Lilly Insulin Raw Material Product
 Table 84. Eli Lilly Recent Developments/Updates
 Table 85. Tonghua Dongbao Company Information
 Table 86. Tonghua Dongbao Description and Business Overview
 Table 87. Tonghua Dongbao Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 88. Tonghua Dongbao Insulin Raw Material Product
 Table 89. Tonghua Dongbao Recent Developments/Updates
 Table 90. Ganlee Company Information
 Table 91. Ganlee Description and Business Overview
 Table 92. Ganlee Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 93. Ganlee Insulin Raw Material Product
 Table 94. Ganlee Recent Developments/Updates
 Table 95. United Laboratory Company Information
 Table 96. United Laboratory Description and Business Overview
 Table 97. United Laboratory Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 98. United Laboratory Insulin Raw Material Product
 Table 99. United Laboratory Recent Developments/Updates
 Table 100. Biocon Company Information
 Table 101. Biocon Description and Business Overview
 Table 102. Biocon Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 103. Biocon Insulin Raw Material Product
 Table 104. Biocon Recent Developments/Updates
 Table 105. Amphastar Company Information
 Table 106. Amphastar Description and Business Overview
 Table 107. Amphastar Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 108. Amphastar Insulin Raw Material Product
 Table 109. Amphastar Recent Developments/Updates
 Table 110. Wockhardt Company Information
 Table 111. Wockhardt Description and Business Overview
 Table 112. Wockhardt Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 113. Wockhardt Insulin Raw Material Product
 Table 114. Wockhardt Recent Developments/Updates
 Table 115. Julphar Diabetes Company Information
 Table 116. Julphar Diabetes Description and Business Overview
 Table 117. Julphar Diabetes Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 118. Julphar Diabetes Insulin Raw Material Product
 Table 119. Julphar Diabetes Recent Developments/Updates
 Table 120. Torrent Pharma Company Information
 Table 121. Torrent Pharma Description and Business Overview
 Table 122. Torrent Pharma Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 123. Torrent Pharma Insulin Raw Material Product
 Table 124. Torrent Pharma Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Insulin Raw Material Distributors List
 Table 128. Insulin Raw Material Customers List
 Table 129. Insulin Raw Material Market Trends
 Table 130. Insulin Raw Material Market Drivers
 Table 131. Insulin Raw Material Market Challenges
 Table 132. Insulin Raw Material Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Insulin Raw Material
 Figure 2. Global Insulin Raw Material Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Insulin Raw Material Market Share by Type: 2024 & 2031
 Figure 4. Regular Human Insulin Product Picture
 Figure 5. Insulin Analogue Product Picture
 Figure 6. Global Insulin Raw Material Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Insulin Raw Material Market Share by Application: 2024 & 2031
 Figure 8. Fast-acting
 Figure 9. Intermediate-acting
 Figure 10. Long-acting
 Figure 11. Global Insulin Raw Material Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Insulin Raw Material Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Insulin Raw Material Sales (2020-2031) & (MT)
 Figure 14. Global Insulin Raw Material Average Price (US$/Kg) & (2020-2031)
 Figure 15. Insulin Raw Material Report Years Considered
 Figure 16. Insulin Raw Material Sales Share by Manufacturers in 2024
 Figure 17. Global Insulin Raw Material Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Insulin Raw Material Players: Market Share by Revenue in Insulin Raw Material in 2024
 Figure 19. Insulin Raw Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Insulin Raw Material Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Insulin Raw Material Sales Market Share by Country (2020-2031)
 Figure 22. North America Insulin Raw Material Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Insulin Raw Material Sales Market Share by Country (2020-2031)
 Figure 26. Europe Insulin Raw Material Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Insulin Raw Material Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Insulin Raw Material Revenue Market Share by Region (2020-2031)
 Figure 34. China Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Insulin Raw Material Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Insulin Raw Material Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Insulin Raw Material Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Insulin Raw Material Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Insulin Raw Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Insulin Raw Material by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Insulin Raw Material by Type (2020-2031)
 Figure 56. Global Insulin Raw Material Price (US$/Kg) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Insulin Raw Material by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Insulin Raw Material by Application (2020-2031)
 Figure 59. Global Insulin Raw Material Price (US$/Kg) by Application (2020-2031)
 Figure 60. Insulin Raw Material Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Insulin Drugs for Diabetes Market Research Report 2024
Global Human Insulin Drugs Market Research Report 2025
Global Human Insulin Regular Market Research Report 2025
Global Insulin Injection Equipment Market Research Report 2025
Global Insulin Analog Market Research Report 2025
Global Insulin Consumables Market Research Report 2024
Global Ultra Long Acting Insulin Market Research Report 2025
Global Oral Insulin Market Research Report 2025
Veterinary Insulin Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Insulin API Market Insights Forecast to 2030
Global Insulin Preparation Market Research Report 2025
Global Human Insulin Market Research Report 2024
Global Recombinant Human Insulin Market Insights Forecast to 2030
Global Human Recombinant Insulin Market Research Report 2024
Global Animal Insulin Market Insights Forecast to 2030
Global Recombinant Insulin Analogue Market Research Report 2024
Global Insulin Management System Market Insights Forecast to 2030
Global Human Insulin Drugs And Delivery Devices Market Insights Forecast to 2030
Global Long Acting Insulin Analogue Market Research Report 2025
Global Diabetes Insulin Pen Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions